ATYR vs BRO · rev $190.0K vs P/E 30, rev $3.58B
aTyr Pharma, Inc. (ATYR) versus Brown & Brown Inc (BRO) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
ATYR currently screens at market cap $471.7M. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Not investment advice. Open the ATYR and BRO stock pages for the full models.
Not investment advice.